PATENT CLAIM ANALYSIS

Application Number: 16114380
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["514", "264100"]

Abstract:
The present invention relates to compounds useful as inhibitors of protein kinases, containing a cysteine residue in the ATP binding site. The invention further provides for pharmaceutically acceptable compositions comprising therapeutically effective amounts of one or more of the protein kinase inhibitor compounds and methods of using said compositions in the treatment of cancers and carcinomas.

Claim (Index 81):
A composition comprising a compound according to  claim 75 , and a pharmaceutically acceptable adjuvant, carrier, or vehicle.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15604786', '15635954', '14212048', '15133755', '14776373']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8689605466141915
- 35 USC 102 Novelty (BERT): 0.6696659517296237
- Combined Prediction Score: 0.8490310871257347
- Mean Citation Score: 486.019652
- Max Citation Score: 503.0517
- Similarity Product: 345.4845750608325

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test